Gradient Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.5M | Buy |
77,648
+3,721
| +5% | +$801K | 0.27% | 114 |
|
|
2026
Q1 | $16.1M | Buy |
73,927
+2,776
| +4% | +$616K | 0.25% | 121 |
|
|
2025
Q4 | $16.3M | Sell |
71,151
-5,726
| -7% | -$1.3M | 0.26% | 117 |
|
|
2025
Q3 | $17.8M | Sell |
76,877
-6,933
| -8% | -$1.41M | 0.3% | 102 |
|
|
2025
Q2 | $15.6M | Buy |
83,810
+4,369
| +5% | +$812K | 0.28% | 108 |
|
|
2025
Q1 | $16.6M | Sell |
79,441
-6,018
| -7% | -$1.17M | 0.34% | 93 |
|
|
2024
Q4 | $15.2M | Buy |
85,459
+7,894
| +10% | +$1.45M | 0.31% | 93 |
|
|
2024
Q3 | $15.3M | Sell |
77,565
-17,642
| -19% | -$3.29M | 0.32% | 92 |
|
|
2024
Q2 | $16.3M | Buy |
95,207
+1,320
| +1% | +$219K | 0.37% | 87 |
|
|
2024
Q1 | $17.1M | Buy |
93,887
+84,448
| +895% | +$14.6M | 0.4% | 81 |
|
|
2023
Q4 | $1.46M | Sell |
9,439
-94
| -1% | -$13.7K | 0.04% | 179 |
|
|
2023
Q3 | $1.42M | Sell |
9,533
-1,909
| -17% | -$280K | 0.04% | 166 |
|
|
2023
Q2 | $1.54M | Sell |
11,442
-3,958
| -26% | -$580K | 0.04% | 165 |
|
|
2023
Q1 | $2.45M | Buy |
15,400
+29
| +0.2% | +$4.43K | 0.07% | 155 |
|
|
2022
Q4 | $2.48M | Buy |
15,371
+11
| +0.1% | +$1.69K | 0.08% | 162 |
|
|
2022
Q3 | $2.06M | Buy |
15,360
+196
| +1% | +$28.1K | 0.06% | 165 |
|
|
2022
Q2 | $2.32M | Buy |
15,164
+930
| +7% | +$142K | 0.07% | 165 |
|
|
2022
Q1 | $2.31M | Sell |
14,234
-303
| -2% | -$44K | 0.06% | 154 |
|
|
2021
Q4 | $1.97M | Buy |
14,537
+6,052
| +71% | +$715K | 0.05% | 156 |
|
|
2021
Q3 | $915K | Sell |
8,485
-99,303
| -92% | -$11.3M | 0.03% | 175 |
|
|
2021
Q2 | $12.1M | Buy |
107,788
+3,043
| +3% | +$343K | 0.36% | 69 |
|
|
2021
Q1 | $11.3M | Sell |
104,745
-2
| -0% | -$214 | 0.37% | 59 |
|
|
2020
Q4 | $9.18M | Sell |
104,747
-1,276
| -1% | -$123K | 0.39% | 73 |
|
|
2020
Q3 | $9.29M | Sell |
106,023
-2,530
| -2% | -$238K | 0.39% | 73 |
|
|
2020
Q2 | $10.7M | Sell |
108,553
-6,461
| -6% | -$569K | 0.49% | 56 |
|
|
2020
Q1 | $8.76M | Sell |
115,014
-377
| -0.3% | -$32.1K | 0.47% | 56 |
|
|
2019
Q4 | $10.2M | Sell |
115,391
-17,286
| -13% | -$1.44M | 0.46% | 64 |
|
|
2019
Q3 | $10M | Buy |
132,677
+7,521
| +6% | +$516K | 0.49% | 49 |
|
|
2019
Q2 | $9.1M | Buy |
125,156
+28,385
| +29% | +$2.23M | 0.47% | 58 |
|
|
2019
Q1 | $7.8M | Sell |
96,771
-4,608
| -5% | -$377K | 0.5% | 51 |
|
|
2018
Q4 | $9.35M | Buy |
101,379
+590
| +0.6% | +$51.9K | 0.56% | 30 |
|
|
2018
Q3 | $9.53M | Buy |
100,789
+19,036
| +23% | +$1.81M | 0.49% | 45 |
|
|
2018
Q2 | $7.57M | Buy |
81,753
+7,020
| +9% | +$686K | 0.4% | 74 |
|
|
2018
Q1 | $7.07M | Sell |
74,733
-10,241
| -12% | -$1.12M | 0.38% | 76 |
|
|
2017
Q4 | $8.22M | Sell |
84,974
-18,988
| -18% | -$1.79M | 0.47% | 44 |
|
|
2017
Q3 | $9.24M | Buy |
103,962
+385
| +0.4% | +$29.3K | 0.59% | 22 |
|
|
2017
Q2 | $7.51M | Buy |
103,577
+4,894
| +5% | +$329K | 0.53% | 32 |
|
|
2017
Q1 | $6.43M | Buy |
98,683
+13,985
| +17% | +$879K | 0.49% | 43 |
|
|
2016
Q4 | $5.3M | Buy |
84,698
+11,378
| +16% | +$695K | 0.46% | 60 |
|
|
2016
Q3 | $4.62M | Buy |
73,320
+4,884
| +7% | +$316K | 0.45% | 59 |
|
|
2016
Q2 | $4.24M | Buy |
68,436
+5,941
| +10% | +$362K | 0.46% | 59 |
|
|
2016
Q1 | $3.57M | Buy |
62,495
+4,515
| +8% | +$252K | 0.44% | 71 |
|
|
2015
Q4 | $3.44M | Buy |
57,980
+2,922
| +5% | +$168K | 0.46% | 63 |
|
|
2015
Q3 | $3M | Sell |
55,058
-4,597
| -8% | -$299K | 0.43% | 73 |
|
|
2015
Q2 | $4.01M | Sell |
59,655
-694
| -1% | -$45.3K | 0.55% | 36 |
|
|
2015
Q1 | $3.53M | Buy |
60,349
+11,321
| +23% | +$684K | 0.53% | 55 |
|
|
2014
Q4 | $3.21M | Sell |
49,028
-4,249
| -8% | -$268K | 0.53% | 61 |
|
|
2014
Q3 | $3.08M | Buy |
53,277
+4,380
| +9% | +$243K | 0.56% | 32 |
|
|
2014
Q2 | $2.76M | Buy |
48,897
+5,828
| +14% | +$306K | 0.54% | 32 |
|
|
2014
Q1 | $2.21M | Buy |
43,069
+4,343
| +11% | +$219K | 0.51% | 36 |
|
|
2013
Q4 | $2.04M | Buy |
38,726
+4,876
| +14% | +$240K | 0.54% | 29 |
|
|
2013
Q3 | $1.51M | Buy |
33,850
+5,804
| +21% | +$257K | 0.48% | 49 |
|
|
2013
Q2 | $1.16M | Buy |
+28,046
| New | +$1.23M | 0.44% | 64 |
|
Other funds holding ABBV
Gradient Investments's ABBV Position: Q2 2026 in Review
Gradient Investments increased its AbbVie (ABBV) stake by 5% in Q2 2026, buying an estimated $801K and bringing the position to 77,648 shares worth $19.5M. The position accounts for 0.27% of the portfolio, ranked #114.
Gradient Investments first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Gradient Investments held 77,648 shares of AbbVie worth $19.5M as of Q2 2026.
- Gradient Investments bought 3,721 AbbVie shares in Q2 2026, an estimated $801K.
- AbbVie made up 0.27% of Gradient Investments's portfolio in Q2 2026, its #114 holding.
- Gradient Investments first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.